BACKGROUND AND AIMS: Intestinal alkaline phosphatase (IAP) is a gut mucosal defense factor known to dephosphorylate lipopolysaccharide (LPS); however, the role of IAP in the gut response to luminal bacteria remains poorly defined. We investigated immune responses of wild-type (WT) and IAP-knockout (IAP-KO) mice to LPS and Salmonella typhimurium challenges. METHODS: Cryostat sectioning and standard indirect immunohistochemical staining for major histocompatibility complex (MHC) class II molecules were performed on liver tissue from WT and IAP-KO mice. WT and IAP-KO mice were orally gavaged with S. typhimurium; bacterial translocation to mesenteric nodes, liver, and spleen was determined by tissue homogenization and plating. In other experiments, WT and IAP-KO mice received intraperitoneal injections of LPS, with subsequent quantification of complete blood counts and serum interleukin (IL)-6 by enzyme-linked immunosorbent assay (ELISA). WT and IAP-KO whole blood were plated and stimulated with LPS and Pam-3-Cys, followed by cytokine assays. RESULTS: Immunohistologic liver examinations showed increased expression of MHC class II molecules in IAP-KO mice. Following S. typhimurium challenge, WT mice appeared moribund compared with IAP-KO mice, with increased bacterial translocation. WT mice had >50% decrease (P<.005) in platelets and 1.8-fold (P<.05) increased serum IL-6 compared with IAP-KO mice in response to LPS injections. IAP-KO whole-blood stimulation with LPS and Pam-3-Cys resulted in increased IL-6 and tumor necrosis factor (TNF)-alpha secretion compared with WT. CONCLUSIONS: IAP-KO mice exhibit characteristics consistent with local LPS tolerance. Whole-blood response of IAP-KO mice did not reflect systemic tolerance. These data suggest that IAP is a local immunomodulating factor, perhaps regulating LPS-toll-like receptor 4 (TLR4) interaction between commensal microflora and intestinal epithelium.
BACKGROUND AND AIMS: Intestinal alkaline phosphatase (IAP) is a gut mucosal defense factor known to dephosphorylate lipopolysaccharide (LPS); however, the role of IAP in the gut response to luminal bacteria remains poorly defined. We investigated immune responses of wild-type (WT) and IAP-knockout (IAP-KO) mice to LPS and Salmonella typhimurium challenges. METHODS: Cryostat sectioning and standard indirect immunohistochemical staining for major histocompatibility complex (MHC) class II molecules were performed on liver tissue from WT and IAP-KO mice. WT and IAP-KO mice were orally gavaged with S. typhimurium; bacterial translocation to mesenteric nodes, liver, and spleen was determined by tissue homogenization and plating. In other experiments, WT and IAP-KO mice received intraperitoneal injections of LPS, with subsequent quantification of complete blood counts and serum interleukin (IL)-6 by enzyme-linked immunosorbent assay (ELISA). WT and IAP-KO whole blood were plated and stimulated with LPS and Pam-3-Cys, followed by cytokine assays. RESULTS: Immunohistologic liver examinations showed increased expression of MHC class II molecules in IAP-KO mice. Following S. typhimurium challenge, WT mice appeared moribund compared with IAP-KO mice, with increased bacterial translocation. WT mice had >50% decrease (P<.005) in platelets and 1.8-fold (P<.05) increased serum IL-6 compared with IAP-KO mice in response to LPS injections. IAP-KO whole-blood stimulation with LPS and Pam-3-Cys resulted in increased IL-6 and tumor necrosis factor (TNF)-alpha secretion compared with WT. CONCLUSIONS:IAP-KO mice exhibit characteristics consistent with local LPS tolerance. Whole-blood response of IAP-KO mice did not reflect systemic tolerance. These data suggest that IAP is a local immunomodulating factor, perhaps regulating LPS-toll-like receptor 4 (TLR4) interaction between commensal microflora and intestinal epithelium.
Authors: H C Rath; M Schultz; R Freitag; L A Dieleman; F Li; H J Linde; J Schölmerich; R B Sartor Journal: Infect Immun Date: 2001-04 Impact factor: 3.441
Authors: Ben E Biesterveld; Shannon M Koehler; Nathan P Heinzerling; Rebecca M Rentea; Katherine Fredrich; Scott R Welak; David M Gourlay Journal: J Surg Res Date: 2015-02-19 Impact factor: 2.192
Authors: Sulaiman R Hamarneh; Byeong-Moo Kim; Kanakaraju Kaliannan; Sara A Morrison; Tyler J Tantillo; Qingsong Tao; Mussa M Rafat Mohamed; Juan M Ramirez; Aaron Karas; Wei Liu; Dong Hu; Abeba Teshager; Sarah Shireen Gul; Konstantinos P Economopoulos; Atul K Bhan; Madhu S Malo; Michael Y Choi; Richard A Hodin Journal: Dig Dis Sci Date: 2017-04-19 Impact factor: 3.199
Authors: David A Shifrin; Russell E McConnell; Rajalakshmi Nambiar; James N Higginbotham; Robert J Coffey; Matthew J Tyska Journal: Curr Biol Date: 2012-03-01 Impact factor: 10.834
Authors: Wei Liu; Dong Hu; Haizhong Huo; Weifeng Zhang; Fatemeh Adiliaghdam; Sarah Morrison; Juan M Ramirez; Sarah S Gul; Sulaiman R Hamarneh; Richard A Hodin Journal: J Am Coll Surg Date: 2015-12-18 Impact factor: 6.113
Authors: Robert J Ardecky; Ekaterina V Bobkova; Tina Kiffer-Moreira; Brock Brown; Santhi Ganji; Jiwen Zou; Ian Pass; Sonoko Narisawa; Flávia Godoy Iano; Craig Rosenstein; Anton Cheltsov; Justin Rascon; Michael Hedrick; Carlton Gasior; Anita Forster; Shenghua Shi; Russell Dahl; Stefan Vasile; Ying Su; Eduard Sergienko; Thomas D Y Chung; Jonathan Kaunitz; Marc F Hoylaerts; Anthony B Pinkerton; José Luis Millán Journal: Bioorg Med Chem Lett Date: 2013-12-19 Impact factor: 2.823
Authors: Kevin M Riggle; Rebecca M Rentea; Scott R Welak; Kirkwood A Pritchard; Keith T Oldham; David M Gourlay Journal: J Surg Res Date: 2012-11-08 Impact factor: 2.192